In addition, melanomas with brain metastases (BM) showed higher expression levels of fibronectin, CTLA-4, CD27, and PanCK compared to tumors with metastases in other organs (OOM) (Table 3, Figures 2d–f). This evidence concerns the gene FN1 and melanoma.